VEGF‐D‐mediated signaling in tendon cells is involved in degenerative processes
Open Access
- 19 January 2022
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 36 (2), e22126
- https://doi.org/10.1096/fj.202100773rrr
Abstract
Vascular endothelial growth factor (VEGF) signaling is crucial for a large variety of cellular processes, not only related to angiogenesis but also in nonvascular cell types. We have previously shown that controlling angiogenesis by reducing VEGF-A signaling positively affects tendon healing. We now hypothesize that VEGF signaling in non-endothelial cells may contribute to tendon pathologies. By immunohistochemistry we show that VEGFR1, VEGFR2, and VEGFR3 are expressed in murine and human tendon cells in vivo. In a rat Achilles tendon defect model we show that VEGFR1, VEGFR3, and VEGF-D expression are increased after injury. On cultured rat tendon cells we show that VEGF-D stimulates cell proliferation in a dose-dependent manner; the specific VEGFR3 inhibitor SAR131675 reduces cell proliferation and cell migration. Furthermore, activation of VEGFR2 and -3 in tendon-derived cells affects the expression of mRNAs encoding extracellular matrix and matrix remodeling proteins. Using explant model systems, we provide evidence, that VEGFR3 inhibition prevents biomechanical deterioration in rat tail tendon fascicles cultured without load and attenuates matrix damage if exposed to dynamic overload in a bioreactor system. Together, these results suggest a strong role of tendon cell VEGF signaling in mediation of degenerative processes. These findings give novel insight into tendon cell biology and may pave the way for novel treatment options for degenerative tendon diseases.Keywords
This publication has 31 references indexed in Scilit:
- A novel in vitro loading system for high frequency loading of cultured tendon fasciclesMedical Engineering & Physics, 2013
- Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesisCellular and Molecular Life Sciences, 2011
- Systems biology of pro‐angiogenic therapies targeting the VEGF systemWires Systems Biology and Medicine, 2010
- Generation of transgenic tendon reporters, ScxGFP and ScxAP, using regulatory elements of the scleraxis geneDevelopmental Dynamics, 2007
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cellsCancer Cell, 2006
- Cyclic tensile strain upregulates collagen synthesis in isolated tendon fasciclesBiochemical and Biophysical Research Communications, 2005
- Ex vivo static tensile loading inhibits MMP‐1 expression in rat tail tendon cells through a cytoskeletally based mechanotransduction mechanismJournal of Orthopaedic Research, 2004
- Expression of the VEGF receptor-3 in osteoarthritic chondrocytes: stimulation by interleukin-1? and association with ?1-integrinsHistochemistry and Cell Biology, 2003
- Interleukin-1βUpregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine KinasesJournal of Molecular and Cellular Cardiology, 1999